HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 04-17-2006, 01:37 PM   #21
Helen
Senior Member
 
Join Date: Sep 2005
Location: Central Valley, CA
Posts: 73
You and your Mom are in my thoughts and prayers.

Best Wishes,
Helen
__________________
  • Diagnosed May 2005 8 months after giving birth. Stage IV due to a single liver mets.
  • Carbo/Taxotere/ Herceptin combo for 6 months
  • Herceptin/ Navelbine
  • Recurrence on the same liver spot in 7/07
  • Liver resection 9/07
  • Tykerb/xeloda 10/22/07
  • NED since 9/07 and continued Tykerb/xeloda
  • PET/CT in May 2009 show small spot in lungs. Continued Tykerb/xeloda
  • PET/CT in Aug 2009 shows progression on lung nodules (slightly bigger)
  • Onc considering Taxol/avastin
Helen is offline   Reply With Quote
Old 04-17-2006, 08:45 PM   #22
Jean
Senior Member
 
Join Date: Oct 2005
Location: New Jersey
Posts: 3,154
Strength

Tom,
Sorry to hear the news of your Mom. I will keep her in my prayers.


Lani,
As you mentioned - knowledge is power - no need to react or panic
with new information - lets use it to empower us!

Thank you Lani,
Jean
Jean is offline   Reply With Quote
Old 04-17-2006, 10:23 PM   #23
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Tom

I wouldn't take this as gospel, just a preliminary study on far too few people with far too many different backgrounds (type of her2 ie E+ vsa E-, types of previous treatments/subsequent treatments), types of chemo, endocrine therapy. but as it is open access you might want to read it in its entirety:

OPEN ACCESS: Outcome of Patients with HER2-Positive Advanced Breast Cancer Progressing During Trastuzumab-Based Therapy [The Oncologist; Subscribe; Sample]
We sought to describe patterns of treatment and clinical outcome in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy. One hundred eighty-four consecutive HER2-positive advanced breast cancer patients received trastuzumab-based therapy between September 1999 and September 2004. Patients were followed up until death or May 2005. For patients progressing on trastuzumab-based therapy, we calculated the response rate (RR) to the first post-progression treatment, overall survival (OS) from the first administration of trastuzumab, time to second progression (TT-SP), and post-progression survival (PPS), according to treatment. At the time of this analysis, 132 patients had progressed on trastuzumab-based therapy, and 89 had died. Of the progressing patients, 21 experienced rapid progression and could not receive additional anticancer treatments;40 patients continued trastuzumab either alone (12 patients with isolated central nervous system progression), with chemotherapy (23 patients), or with endocrine therapy (5 patients); and 71 stopped trastuzumab and received chemotherapy (61 patients) or endocrine therapy (10 patients) as the first post-progression treatment. Excluding patients with rapid progression, clinical outcomes were similar whether trastuzumab was continued or not, in terms of RR (18% and 27%, respectively), OS (31 and 30 months, respectively), TT-SP (6 and 7 months, respectively), and PPS (21 and 19 months, respectively). The clinical outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy might not be influenced by continuing trastuzumab. The optimal therapeutic strategy in this setting of patients needs evaluation in randomized trials.

I may post this separately for others to think about...

Bottom line: they don't know!
Lani is offline   Reply With Quote
Old 04-18-2006, 06:26 AM   #24
Lyn
A Living Legend
 
Join Date: Oct 2005
Posts: 235
Smile

Hi Tom, I know how devestated you are feeling, I would get another oncologist, this one is working against you and not with you. I had an X-Ray on my knee tibia today, I fell nearly 3 weeks ago and my leg was now aching through the morphine and rest of my pain relief, I was convinced I had fractured it with the radiating pain seeming to get worse, last time I just fell up against the wall and broke my collar bone, but no fracture or anything else this time I have to take more pain relief, same here gone from just problems with lymph glands to cerebal fluid in the spinal chord forming tumours and this came about by stopping the eostrogen blocker, I feel maybe I am not as bad as the surgeon says, no one seems know how the Herceptin works or mutates cells in each individual, we all seem to be unique, age is of no consequence when it comes to treating a human being so a new onc and fast.


Love & Hugs Lyn
Lyn is offline   Reply With Quote
Old 05-18-2006, 09:51 AM   #25
rinaina
Senior Member
 
rinaina's Avatar
 
Join Date: May 2006
Location: northshore suburb of chicago
Posts: 1,093
Images: 2
Don't know what zeloda is. Could someone tell me please. thank you.

rina
rinaina is offline   Reply With Quote
Old 05-19-2006, 09:57 PM   #26
MCS
Senior Member
 
Join Date: Sep 2005
Location: Los Angeles
Posts: 430
Unhappy

I am sorry to hear about progression. I remember reading your long details of flaxseed when I first joined the page. Actually I bought it based upon your recommendations. She's lucky to have you as care giver.No need to apolyze for your mom's age. She is your mother. My own dad has been diagnosed with lung cancer, barely 4 moths after my dx of breast cancer. he's 87 and and has had rads only since he decided against chemo. he's holding his own. it's tough here

she sounds like a real strong gal though. is hard to take this stuff at 82.

keep positive. the answers will come.

XO

MCS ( maria)
MCS is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 10:18 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter